To gain in-depth insight for cellular characteristics of DNPC, we analyzed transcriptomics of human CRPC samples12, defining them as AR pathway active PCa (ARPC), DNPC, and neuroendocrine PCa (NEPC) as previously reported13. The gene discussed is AR; the disease is posterior cortical atrophy.